2024澳科资料1688-资料免费精选
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.10.30
关于同一控制下企业合并追溯调整财务数据的公告
2018.10.30
关于子公司新药获得许可进入临床II期试验的提示性公告
2018.10.29
“162024澳科资料1688”2018年付息公告
2018.10.19
关于证券事务代表辞职的公告
2018.09.27
关于子公司新药获得快速通道审评的提示性公告
2018.09.26
第四届董事会第十七次会议决议公告
2018.09.26
关于控股子公司对外融资暨放弃优先认购权的公告
2018.09.26
关于开展金融衍生品交易业务的公告
2018.09.26
金融衍生品交易可行性报告
2018.09.18
2018年第四次临时股东大会的法律意见书
第一页
上一页
49
50
51
52
53
下一页
最后一页
